Xiaohong Wang, Ph.D.
Dr. Wang brings expertise as an immuno-oncology scientist with research in antibody immunotherapy and CAR-T cell therapy to Stellanova. She has utilized her research skills to identify drug development candidates and study mechanism of action . Partnering with Merck, BMS, GSK she developed functional assays and tumor models for testing combination of immune checkpoint inhibitors and radiation for lung cancer and created the first anti-PD1 resistant lung cancer line and syngeneic lung cancer model. She has furthered her experience in the development of CAR-T cell therapy products. Dr. Wang has authored and co-authored over 14 publications. She holds a B.M. in Medicine and an M.S. in Biochemistry and Molecular Biology from Tongji Medical College. Dr. Wang received her Ph.D. in Immunology from Baylor College of Medicine and postdoc training at MD Anderson Cancer Center.
Deepavali Chakravarti, Ph.D.
Dr. Chakravarti has deep expertise in cancer biology and immunology. Most recently, she served as a post-doctoral fellow in the laboratory of Dr. Ron DePinho at MD Anderson Cancer Center. She has received several prestigious fellowships and grants, including the CPRIT Graduate Scholar Award, Digestive Disease Consortium Pilot Feasibility Funding (NIDDK), in various cell biology studies. She is the primary author or co-author of over 14 molecular and cancer biology publications. Dr. Chakravarti holds a Ph.D. In Biochemistry and Cancer Biology from the University of Texas Health Sciences Center and an M.S. in Biology from the University of Clear Lake.
Selvi Kunnimalaiyaan, M.S.
Ms. Kunnimalaiyaan joins Stellanova with an impressive background in cell oncology, molecular biology, and clinical research that encompassed gene and protein expression, DNA replication, and signal transduction-pathway analysis. She has 10+ years of experience and has brought notable achievements in the cancer molecular biology area by holding various research positions with the University of Wisconsin, Medical College of Wisconsin, and the MD Anderson Cancer Center, serving as an assistant, technologist, and specialist. She is the author of several peer-reviewed articles and book chapters. She holds an M.S. in Microbiology from the University of Wisconsin and a B.S. in Physics from the University of Madras, India.
Caitlin Huddleston, M.S.
Mrs. Huddleston joins Stellanova with a background in medical and molecular genetics, immunology, and microbiology. In her various research roles, Caitlin collaborated with SELEX method development, male reproductive biology/contraception target identification, and therapeutics technologies while she managed laboratory operations. She has served as a teaching assistant for scientific writing and biochemistry and is co-author of a publication on dispensable genes for male fertility. Caitlin holds an M.S. in Cell and Molecular Biology from University of Houston Clear-Lake and a B.S. in Biology from Angelo State University.